Bellevue Forum 2018

Dear Friends of Bellevue, 

Thank you for your participation at the Bellevue Forum 2018. We hope you enjoyed your stay in Klosters!

Your Bellevue Team

Summary & CV's

Summary of all presentations Bellevue Forum 2018PDF
CVs of all speakersPDF



Thursday, January 11

Session 1 "B/different, B/bold"

Innovation growth & convictionsAndré Rüegg, CEO Bellevue GroupPDF
Biotech - investing in leading scienceErich Hunziker, Chairman BB Biotech Ltd.PDF
Swiss biotech opportunitiesDominik Escher, BB Pureos BioventuresPDF
Thinking in generationsBirgitte Olsen, BB Entrepreneur strategiesPDF
Entrepreneurial bankingChristian Zenker, BB Investment PartnersPDF

Session 2 "Swiss Champions"

Presentation PresenterDownload
DKSHStefan P. Butz, CEOPDF
Partners GroupPhilip Sauer, Group Finance and Corp. DevPDF
GuritRudolf Hadorn, CEOPDF
SonovaHartwig Grevener, CFOPDF
u-bloxThomas Seiler, CEOPDF

Friday, January 12

Session 3 "Global investment opportunities"

Capital market - Quo vadis?Klaus Mudra, Norbert Keimling & Lucio SosoPDF
Global technologiesKlaus HommelsPDF


For any further questions please contact Inna Kolenzova: iks(at)


Markets & Opinions / 16.02.2018

BB Biotech publishes its annual report for 2017.

Products & Services / 08.02.2018

Bellevue seeks capital to invest in young, innovative, Swiss biotech companies.

Markets & Opinions / 25.01.2018

Read the current issue with a focus on gene therapies.

Corporate News / 23.01.2018

  Bellevue Group posts expected operating profit of about CHF 29 million, expected net pro...

Markets & Opinions / 19.01.2018

Mid caps overdeliver on innovation and are becoming a key upside trigger.